Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-077891
Filing Date
2026-06-26
Accepted
2026-06-25 20:12:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2618444-1_424b5.htm 424B5 886588
2 GRAPHIC fc_natural-4clr.jpg GRAPHIC 67652
3 GRAPHIC fc_programs-4c.jpg GRAPHIC 88976
4 GRAPHIC fc_proqrpipline-4clr.jpg GRAPHIC 76143
5 GRAPHIC lg_proqr-4c.jpg GRAPHIC 17070
  Complete submission text file 0001104659-26-077891.txt   1232436
Mailing Address ZERNIKEDREEF 9 LEIDEN Netherlands
Business Address ZERNIKEDREEF 9 LEIDEN Netherlands 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282419 | Film No.: 261123558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)